
GC65953
RORγt inverse agonist 23
Also known as N-cyclobutyl-N-(4-ethylphenyl)-4-hydroxy-2-(oxan-4-yl)-3,4-dihydro-2H-chromene-6-sulfonamide
RORγt inverse agonist 23 is a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist
ChemicalCAS2230779-18-5MW471.61FormulaC26H33NO5S
- CAS number
- 2230779-18-5
- Molecular weight
- 471.61
- Formula
- C26H33NO5S
- Solubility
- DMSO : ≥ 100 mg/mL (212·04 mM)
- InChIKey
- NIQAXHRTVPHVOC-UHFFFAOYSA-N
- Catalogue number
- GC65953
- Brand
- GLPBIO
Computed properties PubChem CID 142380380 · XLogP 4.3 · TPSA 84.5 Ų · H-bond donors 1
- XLogP
- 4.3
- TPSA
- 84.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES CCC1=CC=C(C=C1)N(C2CCC2)S(=O)(=O)C3=CC4=C(C=C3)OC(CC4O)C5CCOCC5
Computed descriptors from PubChem (CID 142380380), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il